{"gao_id": "GAO-26-108784", "published": "2025-10-23T12:00:00Z", "released": "2025-11-17T07:00:00Z", "summary": "We testified on the 340B Drug Discount Program before the U.S. Senate Committee on Health, Education, Labor & Pensions. Our statement is based primarily on the following reports: Drug Discount Program: Federal Oversight of Compliance at 340B Contract Pharmacies Needs Improvement 340B Drug Discount Program: Increased Oversight Needed to Ensure Nongovernmental Hospitals Meet Eligibility Requirements 340B Drug Discount Program: Oversight of the Intersection with the...", "title": "340B Drug Discount Program: Agency Oversight Has Improved, but Actions Needed to Address Weaknesses", "topics": [], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-26-108784", "versions": []}